Skip to content

The Sedative Effects of Lavender on Social Anxiety and an Examination of Their Psychological and Neuroscientific Mechanisms

Verification of the sedative effects of lavender essential oil inhalation on anticipatory social anxiety: An investigation using psychological and neuroscientific measures - Neuropsychological effects of lavender on anticipatory social anxiety

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061571
Enrollment
34
Registered
2026-05-15
Start date
2026-05-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Lavender flavor Odorless

Sponsors

Institute of Development, Aging and Cancer, Tohoku University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: -Native Japanese speakers -Individuals who do not experience strong aversion to the scent of lavender -Right-handed individuals -Individuals who have never been diagnosed by a doctor with a smell disorder -Individuals with no fragrance allergies -Non-smokers

Exclusion criteria

Exclusion criteria: -Individuals who have been diagnosed by a physician with a disorder of the sense of smell -Individuals with chronic rhinitis or other conditions that may affect the sense of smell -Individuals who are pregnant or breastfeeding -Individuals with a history of severe mental illness or currently undergoing treatment for such conditions -Individuals with a history of severe neurological disorders (e.g., epilepsy, severe traumatic brain injury, central nervous system disorders) or currently suffering from progressive neurological diseases -Individuals with severe respiratory diseases or a history of asthma attacks, for whom exposure to fragrances poses a health risk -Currently undergoing psychotherapy; -Unable to provide informed consent; -History of severe allergic reactions to fragrances (e.g., anaphylaxis) or significant fragrance intolerance; -Physical or cognitive limitations that would interfere with study participation; -Any other individuals whom the principal investigator determines would compromise the safety or validity of the data in this study.

Design outcomes

Primary

MeasureTime frame
Subjective Assessment of Anxiety

Secondary

MeasureTime frame
The "Quality of Task Preparation" During the Anticipatory Anxiety Phase and Prefrontal Cortex Activity Measured by Functional Near-Infrared Spectroscopy (fNIRS)

Countries

Japan

Contacts

Public ContactKiwa Tanaka

Institute of Development, Aging and Cancer, Tohoku University Clinical Geriatrics Research Division

tanaka.kiwa.q4@dc.tohoku.ac.jp08087498211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026